Sonara Health Granted Patent For Take-Home Methadone Monitoring System

Revolutionary Monitoring System's Tamper-Evident Label Allows People To More Safely Consume Methadone From Home, Eliminating Daily Clinic Visits

Sonara Health has been granted a U.S. patent for creating a tamper-evident label that facilitates the safe consumption of methadone at home to treat opioid use disorder and fight America’s opioid crisis.

Sonara Health’s remote medication monitoring system includes a tamper-evident label, a patient-facing web application to guide the patient’s daily consumption of methadone at home and a clinician-facing web application to remotely, asynchronously, observe patients dosing. The Sonara remote medication monitoring system helps eliminate the need for patients to visit a clinic every day, which is often a barrier for people who live far away from clinics or who have jobs and family obligations.

Methadone is among the most effective medications approved by the FDA to treat opioid use disorder.

“In a world where we send billionaires to space in reusable rockets, I thought we ought to be able to create a solution that helps patients with opioid use disorder to get their daily medication in a way that does not disrupt their daily lives, all while preserving the safety and efficacy of a proven delivery system,” said Michael Giles, M.D., and CEO of Sonara Health.

The Mark Cuban-backed health-tech company was designed to improve patient-provider trust and promote access to take-home methadone for opioid treatment programs and their patients. Sonara’s mission is to end the opioid epidemic. Staggering data from the CDC showed over 100,000 people died from drug overdoses last year and about two-thirds of those deaths involved fentanyl or another synthetic opioid.

The Sonara medication monitoring system is simple. The patient scans the QR code on the methadone bottle with their smartphone and follows the steps provided for dosing-at-home. Once scanned and opened, the QR code is voided and the label indicates that it has been opened. The phone’s camera then turns on and a video stream of the patient drinking the methadone is uploaded to the clinician-facing application for the care team to review and ensure proper medication handling.

Early adopters of Sonara include the following opioid treatment programs:

BayMark Health Services, Inc.

BAART, Market Street, San Francisco, CA
BAART, Norwood, Sacramento, CA
HCRC, New Bedford, MA
RSONM, Five Points, Albuquerque, NM (coming soon)
RSONM, Roswell, NM (coming soon)
CODA, Inc.

CODA, Portland, OR
CODA, Seaside, OR
New Season Treatment Centers

Augusta Metro Treatment Center, Augusta, GA

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy